Securities code: Sichuan Huiyu Pharmaceutical Co.Ltd(688553) securities abbreviation: 688553 Announcement No.: 2022-001 Sichuan Huiyu Pharmaceutical Co.Ltd(688553)
Announcement of resolutions of the board of directors
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
1、 Convening of board meeting
The 20th meeting of the first board of directors of Sichuan Huiyu Pharmaceutical Co.Ltd(688553) (hereinafter referred to as “the company”) was held on January 11, 2022 in the conference room on the 4th floor of the company, building 3, No. 333 Hanyang Road, Shizhong District, Neijiang City, Sichuan Province. The meeting notice and meeting materials have been sent by e-mail on January 6, 2022. The meeting was attended by 9 directors, 9 directors actually attended, and relevant supervisors and senior executives attended as nonvoting delegates. All directors unanimously agreed and approved the notice, convening time, proposal content and other matters of the meeting. The convening and convening procedures of the meeting comply with the company law of the people’s Republic of China, the securities law of the people’s Republic of China and other laws and regulations, as well as the relevant provisions of the Sichuan Huiyu Pharmaceutical Co.Ltd(688553) articles of association and the rules of procedure of the Sichuan Huiyu Pharmaceutical Co.Ltd(688553) board of directors, which are legal and effective. 2、 Deliberations of the board meeting
(I) deliberated and passed the proposal on using some over raised funds to invest in new projects. Voting results: 9 votes in favor; 0 abstentions; 0 votes against.
(II) deliberated and passed the proposal on foreign investment in private equity funds and related party transactions by wholly-owned subsidiaries
Voting results: 9 votes in favor; 0 abstentions; 0 votes against.
(III) deliberated and passed the proposal on the expected daily connected transactions of the company in 2022
Voting results: 9 votes in favor; 0 abstentions; 0 votes against.
(IV) the proposal on convening the first extraordinary general meeting of shareholders in 2022 was deliberated and adopted
Voting results: 9 votes in favor; 0 abstentions; 0 votes against.
3、 Documents for future reference
(I) Sichuan Huiyu Pharmaceutical Co.Ltd(688553) the resolution of the 20th meeting of the first board of directors;
(II) Sichuan Huiyu Pharmaceutical Co.Ltd(688553) independent directors’ independent opinions on relevant matters of the 20th session of the first board of directors.
(III) Sichuan Huiyu Pharmaceutical Co.Ltd(688553) independent directors’ prior approval opinions.
It is hereby announced.
Sichuan Huiyu Pharmaceutical Co.Ltd(688553) board of directors January 12, 2022
